News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
318,425 Results
Type
Article (16102)
Company Profile (304)
Press Release (302013)
Multimedia
Podcasts (76)
Webinars (11)
Section
Business (94313)
Career Advice (199)
Deals (15942)
Drug Delivery (52)
Drug Development (52486)
Employer Resources (39)
FDA (6571)
Job Trends (6739)
News (164810)
Policy (11193)
Tag
Academia (1003)
Accelerated approval (14)
Adcomms (16)
Allergies (87)
Alliances (24081)
ALS (110)
Alzheimer's disease (1032)
Antibody-drug conjugate (ADC) (218)
Approvals (6709)
Artificial intelligence (255)
Autoimmune disease (90)
Automation (15)
Bankruptcy (114)
Best Places to Work (5396)
BIOSECURE Act (8)
Biosimilars (107)
Biotechnology (234)
Bladder cancer (97)
Brain cancer (41)
Breast cancer (322)
Cancer (3064)
Cardiovascular disease (242)
Career advice (177)
Career pathing (5)
CAR-T (231)
CDC (9)
Cell therapy (580)
Cervical cancer (16)
Clinical research (44689)
Collaboration (1047)
Company closure (2)
Compensation (535)
Complete response letters (37)
COVID-19 (1169)
CRISPR (80)
C-suite (488)
Cystic fibrosis (112)
Data (4040)
Denatured (13)
Depression (84)
Diabetes (253)
Diagnostics (2101)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (11)
Drug discovery (165)
Drug pricing (56)
Drug shortages (5)
Duchenne muscular dystrophy (197)
Earnings (38458)
Editorial (23)
Employer branding (4)
Employer resources (36)
Events (53991)
Executive appointments (693)
FDA (8262)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (19)
Funding (974)
Gene editing (166)
Generative AI (20)
Gene therapy (463)
GLP-1 (541)
Government (1292)
Grass and pollen (4)
Guidances (236)
Healthcare (7972)
HIV (18)
Huntington's disease (38)
IgA nephropathy (71)
Immunology and inflammation (190)
Immuno-oncology (16)
Indications (51)
Infectious disease (1286)
Inflammatory bowel disease (150)
Inflation Reduction Act (10)
Influenza (41)
Intellectual property (153)
Interviews (22)
IPO (8467)
IRA (16)
Job creations (1623)
Job search strategy (161)
Kidney cancer (11)
Labor market (22)
Layoffs (258)
Leadership (9)
Legal (1566)
Liver cancer (41)
Longevity (10)
Lung cancer (441)
Lymphoma (269)
Machine learning (21)
Management (9)
Manufacturing (425)
MASH (128)
Medical device (4065)
Medtech (4080)
Mergers & acquisitions (8126)
Metabolic disorders (704)
Multiple sclerosis (95)
NASH (17)
Neurodegenerative disease (201)
Neuropsychiatric disorders (64)
Neuroscience (1858)
NextGen: Class of 2025 (2463)
Non-profit (1066)
Now hiring (29)
Obesity (311)
Opinion (130)
Ovarian cancer (127)
Pain (93)
Pancreatic cancer (136)
Parkinson's disease (202)
Partnered (11)
Patents (277)
Patient recruitment (274)
Peanut (41)
People (30241)
Pharmaceutical (48)
Pharmacy benefit managers (8)
Phase I (16005)
Phase II (20729)
Phase III (13077)
Pipeline (2590)
Policy (99)
Postmarket research (894)
Preclinical (6635)
Press Release (36)
Prostate cancer (143)
Psychedelics (47)
Radiopharmaceuticals (231)
Rare diseases (573)
Real estate (3205)
Recruiting (16)
Regulatory (10566)
Reports (23)
Research institute (1048)
Resumes & cover letters (25)
Rett syndrome (19)
RNA editing (16)
RSV (29)
Schizophrenia (114)
Series A (169)
Series B (128)
Service/supplier (1)
Sickle cell disease (74)
Special edition (17)
Spinal muscular atrophy (119)
Sponsored (19)
Startups (2161)
State (1)
Stomach cancer (6)
Supply chain (46)
Tariffs (32)
The Weekly (62)
Vaccines (368)
Venture capital (54)
Weight loss (183)
Women's health (28)
Worklife (2)
Date
Today (63)
Last 7 days (414)
Last 30 days (1772)
Last 365 days (20035)
2025 (19154)
2024 (22578)
2023 (24688)
2022 (31084)
2021 (32253)
2020 (26971)
2019 (19347)
2018 (14110)
2017 (15598)
2016 (13356)
2015 (16156)
2014 (11644)
2013 (8429)
2012 (8699)
2011 (8850)
2010 (8441)
Location
Africa (192)
Alabama (63)
Alaska (3)
Arizona (81)
Arkansas (7)
Asia (20452)
Australia (3450)
California (6990)
Canada (1883)
China (721)
Colorado (253)
Connecticut (250)
Delaware (219)
Europe (43804)
Florida (903)
Georgia (206)
Hawaii (2)
Idaho (24)
Illinois (438)
India (39)
Indiana (214)
Iowa (11)
Japan (214)
Kansas (81)
Kentucky (17)
Louisiana (13)
Maine (47)
Maryland (804)
Massachusetts (5407)
Michigan (148)
Minnesota (274)
Mississippi (4)
Missouri (44)
Montana (17)
Nebraska (6)
Nevada (41)
New Hampshire (44)
New Jersey (1699)
New Mexico (17)
New York (1779)
North Carolina (849)
North Dakota (6)
Northern California (3360)
Ohio (177)
Oklahoma (14)
Oregon (26)
Pennsylvania (1280)
Puerto Rico (10)
Rhode Island (28)
South America (309)
South Carolina (24)
South Dakota (1)
Southern California (2758)
Tennessee (83)
Texas (925)
United States (23592)
Utah (109)
Virginia (139)
Washington D.C. (37)
Washington State (562)
West Virginia (3)
Wisconsin (38)
Wyoming (1)
318,425 Results for "expansion therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
November 5, 2025
·
14 min read
Press Releases
NRG Therapeutics Announces Further Expansion with the Appointment of Paul Thompson as Chief Development Officer
December 1, 2025
·
4 min read
Press Releases
Bachem Announces Progress in Building K Start-Up and Expansion of Its Site in Vista, CA
• The capacity expansion in Bubendorf reached another important milestone with the inspection of Building K. The announced start-up is proceeding according to plan. • In Vista, CA, Bachem acquired a property adjacent to its existing facility. The acquisition will enable a future capacity expansion at the Vista site, thereby strengthening Bachem’s presence in the US market.
October 23, 2025
·
2 min read
Press Releases
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
August 28, 2025
·
3 min read
Press Releases
Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research & Development Webcast
November 14, 2025
·
7 min read
Press Releases
Cartesian Therapeutics Announces Strong Efficacy Signal in Phase 2 Trial of Descartes-08 in Patients with SLE and Expansion of Clinical Development into Myositis
November 14, 2025
·
11 min read
Press Releases
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
October 9, 2025
·
6 min read
Press Releases
AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer
December 3, 2025
·
4 min read
Press Releases
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
December 8, 2025
·
9 min read
Press Releases
Summit Therapeutics Announces Expansion of Ivonescimab Global Phase III Development Program with HARMONi-GI3 Study in 1L Colorectal Cancer
October 20, 2025
·
12 min read
1 of 31,843
Next
